Article Information
History
- December 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nitu Kumaria,b,
- Subasa Chandra Bishwalc,
- Shweta Chaudharyc,
- Deepankar Malalkard,
- Uma S. Dubeyb,
- Pawan Vasudevae,
- Anup Kumare,
- Sunita Saxenaa,
- Ranjan Kumar Nandac,* and
- Usha Agrawala,*
- aNational Institute of Pathology, Indian Council of Medical Research, New Delhi, India, 110029
- bBirla Institute of Technology and Science, Pilani, Rajasthan, India, 333031
- cTranslational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi Component, Aruna Asaf Ali Marg, New Delhi, India,110067
- dSciex, Gurgaon, Haryana, India
- eDepartment of Urology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India, 110029
- ↵*Corresponding author(s):
Usha Agrawal (MD, PhD). National Institute of Pathology, Indian Council of Medical Research, New Delhi, India,110029. E. mail: ushakaggarwal.nip{at}gov.in, Ranjan Kumar Nanda (PhD). Group Leader, Translational Health Group, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi Component, Aruna Asaf Ali Marg, New Delhi, India,110067. E. mail: ranjan{at}icgeb.res.in
Author contributions: NK, RKN and UA designed the project; NK, SCB and DM performed experiments; SCB, SC, NK, USD, SS, RKN and UA contributed reagents/analytic tools and assisted in logistic support; AK, PV treated the patients and provided follow-up; NK, SC, RKN and UA analyzed data, drafted the paper and final edition was agreed upon by all authors.
Posted December 14, 2021.
Proteomics analysis in urinary bladder cancer patients identifies urinary SOD2 as a predictive marker of recurrence
